Kadimastem Ltd (TLV:KDST)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,566.00
-26.00 (-1.00%)
Aug 5, 2025, 10:45 AM IDT
-1.00%
Market Cap108.70M
Revenue (ttm)n/a
Net Income (ttm)-26.55M
Shares Out4.19M
EPS (ttm)-6.33
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume270
Average Volume7,486
Open2,592.00
Previous Close2,592.00
Day's Range2,566.00 - 2,617.00
52-Week Range515.00 - 2,797.00
Beta0.39
RSI56.59
Earnings DateAug 28, 2025

About Marathon Oil

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 11
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol KDST
Full Company Profile

Financial Performance

Financial numbers in GBP Financial Statements

News

There is no news available yet.